Home
/
Department Overview
/
Committee Office
The Hubei Rehabilitation & Nursing Tech Industry（HBRNTI）Academic and Technical Committee (referred to as the Committee) is a professional body within the HBRNTI. It is composed mainly of experts from Academia bodies, Government authorities, Fintech & healthcare industries. The Committee established through self-recommendation, committee recommendation and approval by the board of Institute Directors. The committee aims to drive the development of healthcare & wellness technology innovation, advance healthcare and welfare relevant achievements transformation and commercialisation, and promote regional economic development, which is the showcase of the collaboration of government, industry, academia, research, and finance working together. The Committee is responsible for organizing healthcare and welfare intelligence community, promoting technology achievements commercialisation, and driving technological innovation of research and development.
1. Establishing a “ healthcare and welfare intelligence community”: This specific healthcare and welfare industrial think tank gathers academicians, experts, and entrepreneurs from various relevant fields globally, serving as an important intellectual support for the Committee. It is responsible for providing consultations and arguments related to the strategic framework and industry application scenarios of healthcare and welfare industries, coordinating talent attraction and investment promotion with local governments, and promoting the integration and innovative development of enterprises, universities, and local economics.
2. Promoting transformation and commercialisation: Through the top-level industrial strategic framework, feasible industry application scenarios and real market demand of the health care industry, and integrates the resources of government, industry, academia, research, finance, underlay healthcare big-data and industry technology map, promote the targeted transformation and commercialisation of scientific and technological achievements by academicians and Fintech professionals, and empower enterprises with technological innovation, performance growth, M&A and IPO, etc.
3. Driving Technological Innovation: Each year, 3-5 academicians and experts from the committee intelligence community are selected to lead the construction of various research group within the institute. Additionally, the establishment of the “Frontier Healthcare and welfare Technology Innovation Fund” will advance forward-looking fundamental research and specific key technical breakthroughs in the field of the healthcare and welfare industry.
Since 2021, HBRNTI Academic and Technical Committee has established intelligence community, which has already introduced hundreds of academicians and expert professors from relevant fields globally. The Committee is composed of a director, sectary, and committee fellows. Committee fellows are selected annually from the Committee’s intelligence community. The Committee also has a long tern office responsible for its daily operations, under supervision of the director, providing professional development consultations and technical support for the institute, as well as consultations and support for various activities related to healthcare and welfare technology industry development and technology transformation and commercialisation, including expert evaluations and fellow selections.
Constitution of the Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI)
Chapter 1 General Provisions
1. In order to facilitate the implementation of the development and construction work of Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI), and to regulate the work of the Industry Technical Committee (hereinafter referred to as the “Committee”) of the Rehabilitation and Nursing Tech Industry Institute, this constitution is hereby formulated.
2. To promote the standardised and professional development of the Hubei rehabilitation and nursing tech industry, and to advance the construction of the Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI), the Institute’s Board of Directors shall establish the Committee according to the work needs, and determine its name, responsibilities, etc.
3. The Committee operates under the leadership of the Institute’s Board of Directors.
4. The Committee mainly consists of experts from universities, government authorities, the science and technology finance industry, and the health and wellness industry. The Committee is formed through self-recommendation, recommendation, and approval by the Board of Directors.
Chapter 2 Organisational Structure
5. The Committee consists of a Chairman, a Deputy Chairman, and members. The Chairman and Deputy Chairman are appointed by the Board of Directors for a term of 5 years.
6. The Committee has 1 Chairman, and it operates under the leadership of the Chairman. The responsibilities of the Chairman include:
(1) Being responsible for the work of the Committee and completing tasks assigned by the Institute’s Board of Directors;
(2) Regularly reporting to the Institute’s Board of Directors on the progress of the work undertaken by the Committee.
7. The Committee has 1 Deputy Chairman who assists the Chairman in organising and coordinating the development of work standards, evaluations, and promotions of working groups. The responsibilities of the Deputy Chairman include:
(1) Selecting, managing, contacting, and organising the annual work plan of the Committee members and working groups;
(2) Participating in the activities of the Committee, timely reflecting the opinions and suggestions of the Committee;
(3) Assisting the Chairman in organising Committee meetings;
(4) Conducting preliminary review of the addition of Committee members;
(5) Being responsible for drafting and formulating guidelines for health and wellness industry technology and major technology transformation.
8. The number of Committee members is set at more than 11. Candidates voluntarily apply through self-recommendation or recommendation and are approved by the Institute’s Board of Directors to become Committee members.
9. Conditions for Committee Members to Join
(1) Self-recommendation or expert recommendation to determine candidates; and submit the “Application Form for Members of the Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI)” to the Committee;
(2) The Committee submits the candidate’s application materials to the Board of Directors for review and approval.
10. The Committee sets up an office, which is located within the Construction Management Office of Hubei Health and Wellness Technology Industry Research Institute. This office acts as the working institute of the Committee, is led by the Chairman, and is responsible for the daily work of the Committee.
Chapter 3 Member Requirements and Responsibilities
11. Committee members should abide by discipline and law, possess good professional ethics, have a high level of expertise and extensive work experience, care about industry development, endorse the Committee’s constitution, and fulfil their responsibilities as members. Generally, they should meet the following conditions:
(1) Loyal to the country and the Party, with accurate political stance;
(2) Committee members are not restricted by nationality, age, gender, or region;
(3) Willing to serve the construction of the health and wellness technology industry in Hubei, Central China, and even the whole country;
(4) Have achievements or contributions in technology commercialization in universities or their respective industry fields;
(5) Have a deep understanding of or possess rich practical experience in the rehabilitation and nursing tech industry.
12. Responsibilities of Committee Members
(1) Uphold and abide by the Committee’s constitution, actively maintain the overall image and reputation of the Committee;
(2) Keep internal information of the Committee confidential; without approval, members shall not disclose the work content related to the development strategy and organisational activities of the Committee for the Institute;
(3) Promote and implement the policies formulated by the Committee, actively participate in the Committee’s activities, and undertake tasks assigned by the Committee. The number of annual participation in activities should not be less than 2 times.
Chapter 4 Responsibilities of the Health and Wellness Technology Industry Technical Committee
13. Actively participate in the academic and industry development seminars organised by the Institute.
14. Provide professional development advice and technical support to the Institute.
15. Provide consultation and support for various activities organised and planned by the Institute related to the development and technology commercialisation of the rehabilitation and nursing tech industry, and actively participate in expert evaluations and selections of various activities.
16. Actively promotes Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI) and its related activities.
Chapter 5 Miscellaneous
17. This constitution has been deliberated and approved by the Institute’s Board of Directors.
18. Amendments to this constitution require discussion by the Committee’s assembly, obtaining approval by more than 2/3 (including 2/3), and approval by the Board of Directors.
19. The right to interpret this constitution belongs to the Institute’s Board of Directors.
20. Matters not covered in this constitution shall be implemented according to relevant national regulations.
21. This constitution becomes effective from the date of approval by the Board of Directors.
Hubei Rehabilitation and Nursing Tech Industry Institute (HBRNTI)
Construction Management Office
November 1, 2021
Xia Qinghua is an academician of the National Academy of Engineering of Ukraine with a Ph.D. in Robot Control from the National University of Singapore. He is an expert in robotics, flexible thin-film sensors, and electronic skin. He leads the team to develop a multi-dimensional perceptual flexible tactile sensor array that stands at the forefront internationally and is one of the few teams capable of stable mass production. Their products have been sold worldwide and find applications in various fields such as healthcare, robotics, sports and fitness, high-end equipment, semiconductors, aerospace, beauty, and automotive electronics. Some applications include diabetes foot ulcer warning and detection, rehabilitation therapy for patients with muscle weakness or nerve damage, abnormal gait and posture analysis, fall detection and warning, orthodontics, flatness and seal testing, robot caregiving, robot assembly, robot polishing, and more. His clientele includes publicly traded companies on the NASDAQ, Fortune 500 companies, medical institutions, and research institutes.
Foreign member of the Russian Academy of Engineering. He is a chief physician, professor of internal medicine, and a biomedical engineering researcher, as well as a doctoral supervisor. He is recognized as an A-class talent in Guangdong Province. In 2017, he received the second prize of the National Science and Technology Progress Award. He has been named one of China’s highly cited researchers by Elsevier for three consecutive years (2020, 2021, and 2022) and has been listed as one of the top scientists globally for three consecutive years. In 2021, he was ranked among the top 10 most active scholars in the field of nephrology in China, and in 2022, he was ranked among the top 5.
Academician Dai Yong holds various academic positions, including being a distinguished professor and executive director in the School of Medicine at Anhui University of Science and Technology, a professor and director of the Zhejiang Taizhou University Health Research Center at Southern University of Science and Technology, a professor at Jinan University, and the director of the Guangdong Precision Medicine Engineering Technology Research Center for Autoimmune Diseases. He also serves as the director of the Shenzhen Autoimmune Disease Engineering Research Center and holds multiple other chief expert positions.
He is the chief expert in the Department of Rheumatology at Peking University Shenzhen Hospital, the chief expert at the Inflammation and Immune Diseases Research Institute of Shenzhen Peking University Hong Kong University of Science and Technology Medical Center, and the chief expert in the Organ Transplantation Department of the PLA Joint Logistics Support Force 924 Hospital. Additionally, he is the deputy director of the Institute of Nephrology and Blood Purification at Jinan University and the chief scientist at the Shenzhen Bay Laboratory (a key project in Shenzhen’s development).
Throughout his career, he has undertaken and completed 82 research projects at various levels. He has been granted 32 national invention patents and has published 803 papers both domestically and internationally. Among them, 302 papers have been included in SCI, with a total citation count exceeding 6,881 times and a highest single paper citation of 464 times. His H-index is 39. He has edited or participated in writing 9 monographs, including 4 foreign monographs. He has been awarded 29 scientific research achievements, including one second prize of the National Science and Technology Progress Award and 14 provincial and ministerial-level scientific research achievement awards.
Foreign member of the Ukrainian National Academy of Engineering. He is a professor and doctoral supervisor at the School of Optoelectronics at Chengdu University of Information Technology and is also a specially appointed expert in Sichuan Province. During his career, he has been invited to conduct research in nanomedicine and biomedical engineering at various institutions, including the University of Wisconsin, the University of South Florida, and Washington State University in the United States.
Currently, he is a member of the China Association for Science and Technology, a visiting researcher at the Institute of Biomedical Engineering of the Chinese Academy of Medical Sciences, a member of the Nano Biotechnology Branch of the China Medicine and Biotechnology Association, the deputy editor of “Materials Express” (a SCI journal with a Tier 3 ranking by the Chinese Academy of Sciences), a young editor of “Chinese Chemical Letters,” a special editor of “Journal of Biomedical Nanotechnology,” and a member of the American Chemical Society and the American Nano Association.
In recent years, he has published more than 80 SCI-indexed papers in international mainstream journals such as Chem. Soc. Rev., Adv. Funct. Mater., Small, Biomaterials, Theranostics, ACS Appl. Mater. Inter., Anal. Chem., and others. His papers have received over 2700 citations in total, and his personal H-index is 33. Among his publications, 7 papers have been selected as highly cited papers by ESI (Essential Science Indicators), and 1 paper has been recognized as an ESI hot paper.